18F-FluorApoTrace

N/A

Report date: 2024/05/31 20:00:45

Base Information

Drug Name18F-FluorApoTrace
Drug Alias Name18F-FAT
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionCaspase-3 inhibitors
TargetsCaspase-3
Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWashington University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashington University School Of Medicine
Active IndicationsN/A
Inactive IndicationsLymphoma, Large B-Cell, Diffuse

Other Information

ATC CodeN/A
Related LinksN/A